Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus

• المؤلفون الرئيسيون: Kumutnart Chanprapaph, Nathathai Pratumchart, Preeyachat Limtong, Suthinee Rutnin, Chonlaphat Sukasem, Pintusorn Kungvalpivat, Siripich Triamchaisri, Poonkiat Suchonwanit
• مؤلفون آخرون: Ramathibodi Hospital
• التنسيق: مقال
• منشور في: 2022
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://repository.li.mahidol.ac.th/handle/123456789/78325

Dipeptidyl peptidase-4 inhibitor (DPP4i)-associated bullous pemphigoid (BP) has been emerging but whether it has genotype or phenotype differences from idiopathic BP (IBP) remains to be determined. We aimed to compare clinical characteristics, genetic susceptibility, laboratory features, disease act...